Telangana DCA Seizes Overpriced ‘ICONE-200’ At Pharmacy In Quthbullapur

Hyderabad: The Drugs Control Administration, Telangana seized antifungal medicine ‘ICONE-200 Capsules’ (Itraconazole Capsules 200 mg) at Quthbullapur Village, Medchal-Malkajgiri district for over-pricing.

According to the DCA officials, the MRP indicated is very high compared to the ceiling price fixed for the product by the central government.

Upon information, the DCA raided a medical shop located in Quthbullapur Village, Medchal-Malkajgiri district on Monday, July 22.

The product Itraconazole Capsules 200 mg sold under the brand name ‘ICONE-200 Capsules’ is under price control as per Drugs (Prices Control) Order, 2013 and the price of the product shall be as per the ‘Ceiling Price’ fixed by National Pharmaceutical Pricing Authority (NPPA), government of India.

The Central government has set the ceiling price for Itraconazole Capsules 200 mg at Rs 22.12 per capsule, based on the Wholesale Price Index (WPI). However, Mascot Health Series Private Limited is selling the product for Rs 441.24 for a pack of 10 capsules, which amounts to Rs 44.12 per capsule. This pricing violates the Drugs (Prices Control) Order, 2013.

Mascot Health Series Private Limited which is marketing the product selling for Rs 441.24 for 10 capsules i.e. Rs. 44.12 per one capsule, on the label of the product which is a violation of Drugs (Prices Control) Order, 2013.

“The firm overpriced the product. The firm charged an excess of Rs 193.5 for 10 capsules,” said DCA officials.

Further investigation will be carried out and action shall be taken as per the law against all the offenders.

Related Posts

ICMR mandates clinical trials to focus on Indian demography, lifestyle

New Delhi: Most medicines prescribed in India today are based on clinical trials conducted in Western countries. But Indian bodies, diets, and lifestyles are not the same. Prompted by this,…

India’s Medical Devices Market Is Set To Hit $50 Billion By 2030: Rubix Report

New Delhi:  India’s medical devices industry is on a remarkable growth trajectory, with projections indicating it will reach $50.1 billion by 2030, according to a recent report from Rubix Industry…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

ICMR mandates clinical trials to focus on Indian demography, lifestyle

ICMR mandates clinical trials to focus on Indian demography, lifestyle

India’s Medical Devices Market Is Set To Hit $50 Billion By 2030: Rubix Report

India’s Medical Devices Market Is Set To Hit $50 Billion By 2030: Rubix Report

Muradnagar Police Bust Fake Liver-52 DS Herbal Medicine Racket: Three Arrested

Muradnagar Police Bust Fake Liver-52 DS Herbal Medicine Racket: Three Arrested

Massive Eskuf haul seized from train in Agartala

Massive Eskuf haul seized from train in Agartala

Vadodara Police Seize Illegal Steroids and Testosterone Injections from Russia and Austria in Bodybuilding Shop Raid

Vadodara Police Seize Illegal Steroids and Testosterone Injections from Russia and Austria in Bodybuilding Shop Raid

35 drugs manufactured in Telangana fail CDSCO quality checks

35 drugs manufactured in Telangana fail CDSCO quality checks